Concepedia

Tanya T. Kwan

TT

10

Publications

1.5K

Citations

10

H-Index

2017

Active since

Affiliations

Clovis Oncology (United States)(Current)

University Health Network

Memorial Sloan Kettering Cancer Center

The University of Texas MD Anderson Cancer Center

University of Washington

Tanya T. Kwan is an author at Clovis Oncology (United States) specializing in medicine, ovarian cancer, and cancer therapeutics.

ORCID

Top concepts

Publications per year

2017–2022

10

Publications

10

ATR inhibition disrupts rewired homologous recombination and fork protection pathways in PARP inhibitor-resistant BRCA-deficient cancer cells

Stephanie A. Yazinski, Valentine Comaills, Rémi Buisson et al. · Genes & Development · 2017 · 386 citations · Full text

, , +15

Preclinical evaluation of FAP-2286 for fibroblast activation protein targeted radionuclide imaging and therapy

Dirk Zboralski, Aileen Hoehne, Anne Bredenbeck et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2022 · 230 citations · Full text

Molecular and clinical determinants of response and resistance to rucaparib for recurrent ovarian cancer treatment in ARIEL2 (Parts 1 and 2)

Elizabeth M. Swisher, Tanya T. Kwan, Amit M. Oza et al. · Nature Communications · 2021 · 193 citations · Full text

An RNA-based signature enables high specificity detection of circulating tumor cells in hepatocellular carcinoma

Mark Kalinich, Irun Bhan, Tanya T. Kwan et al. · Proceedings of the National Academy of Sciences · 2017 · 156 citations · Full text

An RNA-Based Digital Circulating Tumor Cell Signature Is Predictive of Drug Response and Early Dissemination in Prostate Cancer

David T. Miyamoto, Richard J. Lee, Mark Kalinich et al. · Cancer Discovery · 2018 · 133 citations · Full text

Rows per page

1–5 of 10